Built for compliance professionals who need the full picture, fast.
Three-paragraph expert analysis of the company's breach patterns, trends, and compliance culture.
See exactly where the company ranks by case volume across all 291 pharma companies. Red flag the outliers instantly.
Breaches grouped by topic — Misleading Promotion, High Standards, Prescribing Information — across all Code editions.
Is this company's case volume rising, falling or stable? Essential context for any due diligence review.
The most serious PMCPA ruling — conduct bringing the industry into disrepute — highlighted automatically.
Which cases were appealed, and by whom. Know whether the company fights its rulings or accepts them.
Download a clean, branded report in one click. Ready for board presentations, legal packs, and supplier audits.
Every upheld case listed with clauses, dates, and links to the full ruling.
Subscribe now and pay £1,999/year forever — even when the price rises to £2,499.
One undisclosed Clause 2 ruling can derail a co-promotion, cost a legal case, or damage a brand built over decades. askanzal gives compliance teams the intelligence to act before the damage is done.
After that, the price rises to £2,499/year permanently. Charter Members pay £1,999/year for life — your price is locked, your reputation is protected.
The charter member price is £1,999/year — a £500 saving on the standard £2,499/year price. This offer is available until 31 March 2026. Charter Members lock in this price permanently — no increases when the price rises.
Full Company Intelligence Reports for all 291 pharma companies in the PMCPA database — AI compliance analysis, breach pattern charts, industry ranking, appeal history, year-on-year case trends, Clause 2 flagging, and one-click PDF export.
Currently one login per subscription. Team seat options are on our roadmap for Q2 2026. Charter Members will get early access.
Case data is updated automatically as new PMCPA rulings are published, typically within 24 hours of publication on pmcpa.org.uk.
No. askanzal.com is an independent research and intelligence tool. Reports are for due diligence research only and do not constitute legal or regulatory advice. Always verify information against original PMCPA published cases.
Yes — cancel any time. Your access continues until the end of your annual billing period. No refunds for partial years.
Lock in the charter member price before 31 March 2026.
By registering you agree to our Terms of Service. Annual subscription. Price locked at £1,999/year for charter members.
One real case. One key lesson. Every week — free.
